Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02754570Completed
Open-label trial of pilocarpine in Open-angle glaucoma (OAG) and ocular hypertension, sponsored by University of Colorado Denver. Primary endpoint: Change in Intraocular Pressure From Baseline at 4 weeks. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02754570.